Loss of Payment Assistance for AMD Drugs Strains Patients and Ophthalmologists
Loss of copayment assistance for drugs to treat neovascular age-related macular degeneration forces patients onto alternative, potentially less effective treatment strategies. Patients who switched to bevacizumab required significantly more frequent…
